The Results of Giardiasis Treatment Using Giardicidal Drugs and their Combination with Probiotics in Children: A Retrospective Cohort Study

Background. Giardiasis in children remains an urgent problem, the significance of which is determined by the endemicity for many countries and regions, outbreaks of sporadic epidemics, polymorphism of clinical symptoms, and insufficient treatment efficacy. Objective. Our aim was to study the results of giardiasis treatment using giardicidal drugs or their combination with probiotics in children. Methods. We analyzed the frequency of Giardia lamblia elimination (the main outcome) as a result of giardiasis treatment (laboratory confirmed) in children aged from 3 months to 18 years who received giardicidal drugs (nifuratel, albendazole) or their combination with probiotics based on Saccharomyces boulardii (probiotic 1) and live freeze-dried lactic acid bacteria Lactobacillus acidophilus (L. gasseri), Bifidobacterium infantis, and Enterococcus faecium (probiotic 2) in outpatient or inpatient settings. Additionally, we registered the duration of the main symptoms of giardiasis (abdominal pain, diarrhea), the prevalence of intestinal dysbiosis and lactase deficiency. The considering period is from January 2015 to September 2017. Results. The results of giardiasis treatment were studied in 4 groups: monotherapy with nifuratel (n = 65) or albendazole (n = 64), a combination of nifuratel + probiotic 1 (n = 67) or albendazole + probiotic 2 (n = 64). The groups were comparable by sex, age, and clinical manifestations of the disease. The elimination of lamblia on the 14–16th day of monotherapy with giardicidal drugs was achieved in 56–60%, when combined with probiotics — in 84% of patients for each combination (df = 3, p < 0.001). Against the background of combination therapy, the disease symptoms (abdominal pain, diarrhea, vomiting) were reversed 1.5 times faster; the number of patients with lactase deficiency and intestinal dysbiosis decreased two and more times, under monotherapy with giardicidal drugs — 1.2 times (df = 3, p < 0.001). Conclusion. Giardiasis treatment in children using combination therapy, including giardicidal drugs and probiotics, is more effective than monotherapy with giardicidal drugs.

children, giardiasis, treatment, giardicidal drugs, nifuratel, albendazole, probiotics

1. Pozdneeva OS, Mekhova OG, Kirnosova NS. Parazitarnye bolezni v strukture mnogoprofil’nogo infektsionnogo statsionara. (Conference proceedigs) XV Kongress detskikh infektsionistov Rossii «Аktual’nye voprosy infektsionnoi patologii i vaktsino profilaktiki»; 2016; Moscow. p. 39. (In Russ).

2. Zdravookhranenie v Rossii. Statisticheskii sbornik. Moscow: Rosstat; 2017. 170 р. (In Russ).

3. Kalashnikova TD, Sokolova YaO, Аrakel’yan RS. Kliniko-epidemiologicheskie osobennosti zhiardiaza cheloveka v Astrakhanskoi oblasti. Novaya nauka: Strategiya i vektory razvitiya. 2016;(3–2):51–55. (In Russ).

4. Kornienko EA, Minina SN, Fadina SA, Loboda TB. Clinic, diagnostics and treatment of giardiasis in children. Pediatric Pharmacology. 2009;6(4):40–46. (In Russ).

5. Aleksandrova VA, Odintsova VE. Sravnitel’naya kharakteristika diagnostiki i lecheniya gel’mintno-protozoinykh invazii u detei na sovremennom etape. Practitioner. 2010;(8):66. (In Russ).

6. Faizullina RА. Gardiasis in pediatric patients: specific issues of clinical manifestations, diagnosis, and treatment in current medical practice. Doktor.ru. 2014;(3):23–30. (In Russ).

7. Minina SN. Sovremennye metody diagnostiki i lecheniya lyamblioza u detei. [dissertation abstract] St. Petersburg; 2009. 27 р. (In Russ). http://medical-diss.com/medicina/sovremennye-metody-diagnostiki-i-lecheniya-lyambliozaudetey

8. Kucherya TV. Kliniko-epidemiologicheskie aspekty lyamblioza u detei. [dissertation abstract] Moscow; 2008. 22 р. (In Russ). https://search.rsl.ru/ru/record/01003448717

9. Ermakova LA. Optimizatsiya diagnostiki i lecheniya lyamblioza. [dissertation abstract] Moscow; 2008. 18 р. (In Russ). http://earthpapers.net/optimizatsiya-diagnostiki-i-lecheniyalyamblioza

10. Kildiyarova RR, Mileyko VYe. Diagnosis of giardiasis in children and control of treatment efficiency. Health, demography, ecology of finno-ugric peoples. 2014;(4):35–39. (In Russ).

11. Yershova IB, Mochalova HO, Osypova TF, Petrenko OV. Improving treatment of giardiasis. Actual infectology. 2015;(3):49–54. (In Russ).

12. Solaymani-Mohammadi S, Genkinger JM, Loffredo CA, Singer SM. A meta-analysis of the effectiveness of albendazole compared with metronidazole as treatments for infections with Giardia duodenalis. PLoS Negl Trop Dis. 2010;4(5):e682. doi: 10.1371/journal. pntd.0000682.

13. Shrainer EV, Denisov MYu. Laktaznaya nedostatochnost’ u detei: sovremennoe sostoyanie problemy. Vestnik NGU. Biologiya, klinicheskaya meditsina. 2009;7(4):154–162. (In Russ).

14. Sergiev VP, Lobzin YuV, Kozlov SS. Parazitarnye bolezni cheloveka (protozoozy i gel’mintozy). St. Petersburg; 2006. 592 р. (In Russ).

15. Usenko DV, Kananykhina SYu. Modern aspects of giardiasis diagnosis and treatment. Current pediatrics. 2015;14(1):108–113. (In Russ). doi: 10.15690/vsp.v14i1.1268.

16. Bekhtereva MI, Luppova EN, Kornienko EA, et al. Working protocol for diagnosis and treatment of giardiasis in children. Problems of pediatric nutritiology. 2013;11(6):72–77. (In Russ).

17. Zaat JO, Mank TG, Assendelft WJ. A systematic review on the treatment of giardiasis. Trop Med Int Health. 1997;2(1):63–83. doi: 10.1046/j.1365-3156.1997.d01-132.x.

18. Odintseva VE, Aleksandrova VA. Methods of diagnostics and treatment of intestinal helminth-protozoal invasions in children with diseases of intestinal tract. Detskie infektsii. 2010;9(2):58–66. (In Russ).

19. Perez PF, Minnaard J, Rouvet M, et al. Inbibition of Giardia intestinalis by extracellularis factors from lactobacilli: an in vitro study. Appl Environ Microbiol. 2001;67(11):5037–5042. doi: 10.1128/AEM.67.11.5037-5042.2001.

20. Mazankova LN. Vtorichnyi sindrom laktaznoi nedostatochnosti u detei. Metody dietoterapii i lecheniya. Moscow; 2004. 19 р. (In Russ).

21. Antonenko AN. Laktaznaya nedostatochnost’ u detei rannego vozrasta, bol’nykh ostrymi kishechnymi infektsiyami, osnovnye metody ee korrektsii. [dissertation abstract] Moscow; 2006. 26 р. (In Russ). http://www.crie.ru/pdf/avtoref5(antonenko).pdf

22. Faizullina RG. Lyamblioz u detei: sovremennye podkhody k diagnostike i lecheniyu. Prakticheskaya meditsina. 2008;(7):56–61. (In Russ).

23. Kornienko EF, Minina SN, Fadina SA, et al. Diagnosis and treatment of giardiasis in children. Infectious diseases. 2009;7(1):43–48. (In Russ).

24. Privorotskiy VF, Luppova NYe. Giardiasis in children: the modern state of problem. Pediatr. 2013;4(3):101–110. (In Russ).

25. Humen MA, De Antoni GL, Benyacoub J, et al. Lactobacillus johnsonii La1 antagonizes Giardia intestinalis in vivo. Infect Immun. 2005;73(2):1265–1269. doi: 10.1128/IAI.73.2.1265-1269.2005.